11 results on '"Xu, Y. G."'
Search Results
2. [Long-term efficacy and safety of simultaneous integrated boost radiotherapy in non-operative esophageal squamous cell carcinoma: a multicenter retrospective data analysis (3JECROG R-05)].
- Author
-
Wang XM, Wang L, Wang X, Chen JQ, Li C, Zhang WC, Ge XL, Shen WB, Hu MM, Yuan QQ, Xu YG, Hao CL, Zhou ZG, Qie S, Lu N, Han C, Pang QS, Wang P, Sun XC, Zhang KX, Li GF, Li L, Liu ML, Wang YD, Qiao XY, Zhu SC, Zhou ZM, Zhao YD, and Xiao ZF
- Subjects
- Chemoradiotherapy, Data Analysis, Humans, Retrospective Studies, Esophageal Neoplasms drug therapy, Esophageal Neoplasms radiotherapy, Esophageal Squamous Cell Carcinoma drug therapy, Head and Neck Neoplasms, Radiotherapy, Intensity-Modulated, Stomach Neoplasms
- Abstract
Objective: To analyze the survival benefits and treatment related toxic effects of simultaneous integrated boost intensity-modulated radiotherapy (SIB-RT) for non-operative esophageal squamous cell carcinoma patients. Methods: The data of 2 132 ESCC patients who were not suitable for surgery or rejected operation, and underwent radical radiotherapy from 2002 to 2016 in 10 hospitals of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG) were analyzed. Among them, 518 (24.3%) cases underwent SIB (SIB group) and 1 614 (75.7%) cases did not receive SIB (No-SIB group). The two groups were matched with 1∶2 according to propensity score matching (PSM) method (caliper value=0.02). After PSM, 515 patients in SIB group and 977 patients in No-SIB group were enrolled. Prognosis and treatment related adverse effects of these two groups were compared and the independent prognostic factor were analyzed. Results: The median follow-up time was 61.7 months. Prior to PSM, the 1-, 3-, and 5-years overall survival (OS) rates of SIB group were 72.2%, 42.8%, 35.5%, while of No-SIB group were 74.3%, 41.4%, 31.9%, respectively ( P =0.549). After PSM, the 1-, 3-, and 5-years OS rates of the two groups were 72.5%, 43.4%, 36.4% and 75.3%, 41.7%, 31.6%, respectively ( P =0.690). The univariate survival analysis of samples after PSM showed that the lesion location, length, T stage, N stage, TNM stage, simultaneous chemoradiotherapy, gross tumor volume (GTV) and underwent SIB-RT or not were significantly associated with the prognosis of advanced esophageal carcinoma patients who underwent radical radiotherapy ( P <0.05). Cox model multivariate regression analysis showed lesion location, TNM stage, GTV and simultaneous chemoradiotherapy were independent prognostic factors of advanced esophageal carcinoma patients who underwent radical radiotherapy ( P <0.05). Stratified analysis showed that, in the patients whose GTV volume≤50 cm(3), the median survival time of SIB and No-SIB group was 34.7 and 30.3 months ( P =0.155), respectively. In the patients whose GTV volume>50 cm(3), the median survival time of SIB and No-SIB group was 16.1 and 20.1 months ( P =0.218). The incidence of radiation esophagitis and radiation pneumonitis above Grade 3 in SIB group were 4.3% and 2.5%, significantly lower than 13.1% and 11% of No-SIB group ( P <0.001). Conclusions: The survival benefit of SIB-RT in patients with locally advanced esophageal carcinoma is not inferior to non-SIB-RT, but without more adverse reactions, and shortens the treatment time. SIB-RT can be used as one option of the radical radiotherapy for locally advanced esophageal cancer.
- Published
- 2021
- Full Text
- View/download PDF
3. [Laparoscopic circular stapled gastrointestinal anastomosis using novel device of sealed cap access after total laparoscopic gastrectomy].
- Author
-
Du JJ, Xue HY, Zhao LZ, Zhang ZQ, Xu YG, Hu J, Ye L, Yu CD, and Dong YQ
- Subjects
- Anastomosis, Surgical, China, Gastrectomy, Humans, Surgical Stapling, Laparoscopy, Stomach Neoplasms surgery
- Abstract
Intracorporeal classic gastrointestinal anastomosis using circular stapler in totally laparoscopic gastrectomy (TLG) for gastric cancer requires intracorporeal anvil placement and suitable access for introduction of the circular stapler to the abdominal cavity without gas leak. The novel techniques for anvil placement have been updated, but there is no progress for proper access for circular stapler. In the study, intracorporeal circular-stapled gastrointestinal anastomosis were successfully accomplished using a novel device of sealed cap access with a central hole (WLB-60/70-60/100, Wuhan Widerep Medical Instrument Co.,Ltd, China) customized to the incision protection retractor for the simple and accessible introduction of the circular stapler and anvil under the optimal maintenance of pneumoperitoneum pressure in TLG. In these 3 cases, there was no gas leakage and the pneumoperitoneum was well maintained when performing the gastrointestinal anastomosis, and there was no transition to laparotomy or other anastomosis techniques. The result suggests that the sealed cap access could be a novel choice for introduction of the circular stapler to the abdominal cavity in order to obtain laparoscopic circular-stapled gastroin-testinal anastomosis in TLG.
- Published
- 2021
- Full Text
- View/download PDF
4. [Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)].
- Author
-
Hu MM, Yuan QQ, Zhang XS, Yang S, Wang X, Wang L, Chen JQ, Zhang WC, Wang XM, Ge XL, Shen WB, Xu YG, Hao CL, Zhou ZG, Qie S, Lu N, Pang QS, Zhao YD, Sun XC, Li GF, Li L, Qiao XY, Liu ML, Wang YD, Li C, Zhu SC, Han C, Zhang KX, and Xiao ZF
- Subjects
- China epidemiology, Esophageal Neoplasms mortality, Esophageal Neoplasms pathology, Esophageal Squamous Cell Carcinoma mortality, Esophageal Squamous Cell Carcinoma pathology, Humans, Neoplasm Staging, Radiotherapy, Intensity-Modulated methods, Retrospective Studies, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Chemoradiotherapy methods, Esophageal Neoplasms drug therapy, Esophageal Neoplasms radiotherapy, Esophageal Squamous Cell Carcinoma drug therapy, Esophageal Squamous Cell Carcinoma radiotherapy
- Abstract
Objective: To evaluate the survival and prognostic factors of radiotherapy in patient with Ⅳ stage esophageal squamous carcinoma treated with radiation or chemoradiation. Methods: The medical records of 608 patients with stage Ⅳ esophageal squamous cell carcinoma who met the inclusion criteria in 10 medical centers in China from 2002 to 2016 were retrospectively analyzed. The overall survival and prognostic factors of all patients at 1, 3 and 5 years were analyzed. Results: The 1-, 3-, 5- year overall survival (OS) rates was 66.7%, 29.5% and 24.3% in stage ⅣA patients, and 58.8%, 29.0% and 23.5% in stage ⅣB patients. There was no statistical difference between the two groups ( P =0.255). Univariate analysis demonstrated that the length of lesion, treatment plan, planned tumor target volume (PGTV) dose, subsequent chemotherapy, and degrees of anemia, radiation esophagitis, radiation pneumonia were related to the prognoses of patients with Ⅳ stage esophageal carcinomas after radiotherapy and chemotherapy ( P <0.05). Multivariate analysis demonstrated that PGTV dose ( OR =0.693, P =0.004), radiation esophagitis ( OR =0.867, P =0.038), and radiation pneumonia ( OR =1.181, P =0.004) were independent prognostic factors for OS. Conclusions: For patients with stage Ⅳ esophageal squamous cell carcinoma, chemoradiotherapy followed by sequential chemotherapy is recommended, which can extend the total survival and improve the prognosis of the patients. PGTV dose more than 60 Gy has better efficacy.
- Published
- 2020
- Full Text
- View/download PDF
5. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
- Author
-
Lu N, Wang X, Li C, Wang L, Chen JQ, Zhang WC, Wang XM, Ge XL, Shen WB, Hu MM, Yuan QQ, Xu YG, Hao CL, Zhou ZG, Qie S, Xiao ZF, Zhu SC, Han C, Qiao XY, Pang QS, Wang P, Zhao YD, Sun XC, Zhang KX, Li L, Li GF, Liu ML, and Wang YD
- Subjects
- Antineoplastic Agents therapeutic use, Chemoradiotherapy, Dose-Response Relationship, Radiation, Esophageal Neoplasms drug therapy, Esophageal Neoplasms mortality, Esophageal Neoplasms pathology, Esophageal Squamous Cell Carcinoma drug therapy, Esophageal Squamous Cell Carcinoma mortality, Esophageal Squamous Cell Carcinoma pathology, Humans, Prognosis, Radiotherapy Dosage, Radiotherapy, Conformal, Radiotherapy, Intensity-Modulated, Retrospective Studies, Esophageal Neoplasms radiotherapy, Esophageal Squamous Cell Carcinoma radiotherapy
- Abstract
Objective: To evaluate the prognostic factors of T1-2N0M0 esophageal squamous cell carcinoma (ESCC) treated with definitive radiotherapy. Methods: The clinical data of 196 patients with T1-2N0M0 ESCC who were treated with definitive radiotherapy in 10 hospitals were retrospectively analyzed. All sites were members of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG). Radiochemotherapy were applied to 78 patients, while the other 118 patients received radiotherapy only. 96 patients were treated with three-dimensional conformal radiotherapy (3DCRT) and 100 treated with intensity-modulated radiotherapy (IMRT). The median dose of plan target volume(PTV) and gross target volume(GTV) were both 60 Gy. The median follow-up time was 59.2 months. Log rank test and Cox regression analysis were used for univariat and multivariate analysis, respectively. Results: The percentage of normal lung receiving at least 20 Gy (V(20)) was (18.65±7.20)%, with average dose of (10.81±42.05) Gy. The percentage of normal heart receiving at least 30 Gy (V(30)) was (14.21±12.28)%. The maximum dose of exposure in spinal cord was (39.65±8.13) Gy. The incidence of radiation pneumonia and radiation esophagitis were 14.80%(29/196) and 65.82%(129/196), respectively. The adverse events were mostly grade 1-2, without grade 4 toxicity. Median overall survival (OS) and progression-free survival (PFS) were 70.1 months and 62.3 months, respectively. The 1-, 3- and 5-year OS rates of all patients were 75.1%、57.4% and 53.2%, respectively. The 1-, 3- and 5-year PFS rates were 75.1%、57.4% and 53.2%, respectively. Multivariate analysis demonstrated that patients'age ( HR =1.023, P =0.038) and tumor diameter ( HR =1.243, P =0.028)were the independent prognostic factors for OS, while tumor volume were the independent prognostic factor for PFS. Conclusions: Definitive radiotherapy is a promising therapeutic method in patients with T1-2N0M0 ESCC. Patients' age, tumor diameter and tumor volume may impact patients' prognosis.
- Published
- 2020
- Full Text
- View/download PDF
6. [CT manifestations and prognosis of acute paraquat induced lung injury].
- Author
-
Zhao Y, Tian ZG, Xu T, Gao FH, Guo YY, Wang GJ, and Xu YG
- Subjects
- Acute Lung Injury chemically induced, Humans, Lung diagnostic imaging, Lung pathology, Prognosis, Tomography, X-Ray Computed, Acute Lung Injury diagnostic imaging, Paraquat poisoning
- Abstract
Objective: To investigate the CT features of lung injury induced by paraquat poisoning and its relationship with prognosis, and to provide reference for the judgment of the condition and prognosis of paraquat poisoning. Methods: 146 cases of paraquat poisoning patients were treated in the Third People's Hospital of Xuzhou City from January 2013 to April 2016. The cases were divided into mild group, moderate-severe group and fulminant group according to the concentration of paraquat in urine. The clinical data and CT imaging findings were analyzed and reconstructed in three-dimensional reconstruction. The extent of the lesion was observed and the relationship between CT and prognosis was explored. Results: Paraquat lung injury has many manifestations on CT images, and it's performance can be intersecting at the same time. Early lesions lighter cases, late CT imaging lesions can be completely absorbed or residual fibrosis, the prognosis was good; the early lesion was pulmonary consolidation, pleural effusion cases, the late CT image was usually pleural thickening and bronchiectasis, the prognosis was relatively good; early lesions were large patches of ground glass opacity cases, finally, pulmonary fibrosis was common, the mortality rate of 56.57%. There were significant differences in the extent of lung injury between different groups ( P <0.001) , and the difference in mortality was statistically significant when the lung injury was different ( P <0.001) . Multivariate stepwise Logistic regression analysis showed that ground-glass opacity ( OR value=2.013) , interstitial lung fibrosis ( OR =3.779) and mediastinal emphysema ( OR =33.118) were risk factors for death of lung injury caused by paraquat poisoning ( P <0.05) . Conclusion: There were many manifestations on CT images of paraquat lung injury, and the manifestations of paraquat lung injury can be intersecting at the same time. The pulmonary manifestations and outcomes of different paraquat types were different. The CT manifestations of lung injury in paraquat poisoning were mainly exudative changes at early stage, and can be gradually absorbed or evolved into interstitial changes at later stage. The cumulative damage range can be used as a reference for evaluating the prognosis. Ground-glass opacity, interstitial pulmonary fibrosis and mediastinal emphysema are the risk factors for death of lung injury caused by paraquat poisoning.
- Published
- 2020
- Full Text
- View/download PDF
7. [Spatial-temporal cluster of hemorrhagic fever with renal syndrome in Hebei province, 2005-2016].
- Author
-
Cai YN, Han X, Wei YM, Han ZY, Liu SY, Zhang YB, Xu YG, Qi SX, and Li Q
- Subjects
- China epidemiology, Cities, Cluster Analysis, Humans, Incidence, Seasons, Spatial Analysis, Spatio-Temporal Analysis, Disease Notification statistics & numerical data, Hantaan virus, Hemorrhagic Fever with Renal Syndrome epidemiology, Population Surveillance
- Abstract
Objective: To explore the spatial-temporal distribution and epidemic characteristics of hemorrhagic fever with renal syndrome (HFRS) in Hebei province from 2005 to 2016. Methods: Records of HFRS cases reported from each county in Hebei during January 2005 to December 2016 were collected from National Notifiable Disease Surveillance System (NNDSS). Global and local spatial association statistics were used to measure the spatial autocorrelation and software GeoDa 1.2.0. Software SaTScan 9.4.1 was used to analyze spatiotemporal clusters. Software ArcGIS 10.2 was used to visualize the yearly scan results. Results: In Hebei province, a total of 8 437 human HFRS cases reported from 170 counties with an annual incidence rate of 0.99/100 000 population during 2005-2016. The peak incidence season was spring. Global spatial autocorrelation analysis on the incidence of HFRS at county-level showed that the value of Moran's I were all above 0 ( P <0.05), indicating that the significant spatial cluster. The result of local indicators on spatial association (LISA) analysis revealed that identified hot spots were mainly in northeastern area, while cold spots were found in some counties of central and southern areas. Spatial-temporal scan detected that the primary cluster of HFRS incidence was mainly distributed in Qinhuangdao city and Tangshan city, including 11 counties (city/district): Beidaihe district, Haigang district, Funing district, Shanhaiguan district, Changli county, Lulong county and Qinglong Manchu autonomous county in Qinhuangdao city, and Qian'an city, Laoting county, Luanzhou city and Luannan county in Tangshan city ( RR =39.64, P <0.001), during January-July in 2005. Conclusions: There were significant spatial-temporal cluster of HFRS in Hebei from 2005 to 2016. The cluster areas of HFRS were mainly in northeastern Hebei, it is necessary to strengthen the prevention and control programs of HFRS in these areas.
- Published
- 2019
- Full Text
- View/download PDF
8. [Effect of fuzheng kangbai granule on immune function and survival time in minimal residual leukemia model in mice].
- Author
-
Xu YG, Ma R, and Hu NP
- Subjects
- Animals, Female, Leukemia, Experimental immunology, Lymphocyte Subsets immunology, Male, Mice, Neoplasm, Residual drug therapy, Neoplasm, Residual immunology, Adjuvants, Immunologic pharmacology, Drugs, Chinese Herbal pharmacology, Leukemia, Experimental drug therapy
- Abstract
Objective: To observe the effects of Fuzheng Kangbai Granule (FZKBG) on immune function and survival time in minimal residual leukemia (MRL) model mice and study its mechanism., Methods: MRL model mice were established by hypodermic inoculation with L7212 cells following intraperitoneal injection of cytoxan (CTX) 25 mg/kg 3 days later, and divided into the control group and FZKBG group. The changes of T-lymphocyte subsets, including CD3+, CD4+ and CD8+, and the survival time in model mice were observed., Results: Comparing with the control group, FZKBG could obviously increase both the percentage and absolute value of CD3+ and CD4+ lymphocytes and prolong the survival time of model mice, the prolongation rate being 29.6%-60.4%., Conclusion: FZKBG could markedly prolong the survival time of MRL mice, its mechanism might be through elevating the immune function and inhibiting the leukemic cells in model mice.
- Published
- 2001
9. [Effects of long-term physical training on age-related changes of energy transformation of mice heart mitochondria].
- Author
-
Lu J, Chen CZ, Xu YG, and Lai RX
- Subjects
- Animals, Ketoglutaric Acids metabolism, Male, Mice, Mice, Inbred C57BL, Oxidative Phosphorylation, Running, Aging physiology, Mitochondria, Heart metabolism, Physical Conditioning, Animal physiology
- Abstract
Aim and Methods: To observe effects of long-term physical training (running wheel) on the age-related changes of energy transformation of mice heart mitochondria., Results: RCR and ADP/O decreased with age in the presence of a-ketoglutaric acid, especially in the late of age, which indicated that oxidative phosphorylation coupling decreased in the aging process., Conclusion: Adaptive changes of mitochondria were brought by long-term physical training which might delay the age-related decline of mitochondrial function.
- Published
- 2001
10. [Changes in sodium, calcium and potassium during ischemia and reperfusion of myocardium].
- Author
-
Xu YG and Yang XY
- Subjects
- Animals, Calcium Channels metabolism, Humans, Potassium Channels metabolism, Sodium Channels metabolism, Calcium metabolism, Myocardial Reperfusion Injury metabolism, Potassium metabolism, Sodium metabolism
- Published
- 1993
11. [Protective effects of nicorandil on action potentials in anoxia and reoxygenated ventricular myocardium of guinea pig].
- Author
-
Xu YG, Yang XY, Yao RM, Yang YZ, and Chen HZ
- Subjects
- Action Potentials drug effects, Animals, Anti-Arrhythmia Agents therapeutic use, Cell Hypoxia, Female, Guinea Pigs, In Vitro Techniques, Male, Myocardial Reperfusion, Niacinamide pharmacology, Niacinamide therapeutic use, Nicorandil, Ventricular Function, Anti-Arrhythmia Agents pharmacology, Arrhythmias, Cardiac prevention & control, Myocardium cytology, Niacinamide analogs & derivatives
- Abstract
Standard microelectrode techniques were used to study the effects of nicorandil (500 mumol.L-1) on action potentials in anoxia and reoxygenated ventricular myocardium of guinea pig. The main results: (a) Nicorandil shortened the action potentials duration (APD) and increased the ratio of effective refractory period (ERP) to APD90 (ERP/APD90). It did not cause significant changes in resting potential (RP), the maximal rate of rise of phase 0 (Vmax) and action potential amplitude (APA); (b) Exposure of the preparation to anoxic conditions (hypoxia, acidosis, glucose deprivation, and hyperkalemia) for 20 min, resulted in a marked depolarization of RP, a shortening of APD, reductions of APA and Vmax, and an increase in the ratio of ERP/APD90; (c) Nicorandil did not produce any additional effect on these parameters during anoxia except aggravated shortening of APD; (d) The changes of action potential parameters during anoxia were all completely reversed when the preparation was reoxygenated in the absence of the drug for 20 min. In the presence of the drug, however, APD was only partially reversed; (e) Nicorandil decreased the incidence of abnormal automaticity occurring during reoxygenation from 14/16 to 4/16. It is concluded that nicorandil antagonizes the cellular mechanisms which underlie the reoxygenation arrhythmias and prevent the reoxygenation-induced arrhythmias.
- Published
- 1993
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.